Life Sciences Tools & Services stocks
60 US-listed companies in life sciences tools & services, with $145.6bn of combined revenue in their latest fiscal years. Thermo Fisher Scientific is the largest ($44.6bn). The fastest grower with at least $100m of revenue in both years is Billiontoone, Inc., up 100.0%. The median company grew 3.9% with a net margin of 2.4%.
Companies60
Combined revenue$145.6bn
Median revenue growth3.9%
Median net margin2.4%
Median return on equity2.4%
| # | Company | Revenue | Growth | Net margin | ROE | Fiscal year |
|---|---|---|---|---|---|---|
| 1 | Thermo Fisher ScientificTMO | $44.6bn | 3.9% | 15.0% | 13.0% | 2025 |
| 2 | Danaher CorporationDHR | $24.6bn | 2.9% | 14.7% | 7.1% | 2025 |
| 3 | IQVIAIQV | $16.3bn | 5.9% | 8.3% | 21.6% | 2025 |
| 4 | Icon PLCICLR | $8.3bn | 0.8% | 2.8% | 2.5% | 2025 |
| 5 | Agilent TechnologiesA | $6.9bn | 6.7% | 18.8% | 20.6% | 2025 |
| 6 | Avantor, Inc.AVTR | $6.6bn | −3.4% | −8.1% | −9.2% | 2025 |
| 7 | Illumina, Inc.ILMN | $4.3bn | −0.7% | 19.6% | 33.4% | 2025 |
| 8 | Mettler ToledoMTD | $4.0bn | 4.0% | 21.6% | — | 2025 |
| 9 | Charles River LaboratoriesCRL | $4.0bn | −0.9% | −3.6% | −4.4% | 2025 |
| 10 | Bruker CorpBRKR | $3.4bn | 2.1% | −0.3% | −0.4% | 2025 |
| 11 | Waters CorporationWAT | $3.2bn | 7.0% | 20.3% | 29.3% | 2025 |
| 12 | Fortrea Holdings Inc.FTRE | $2.7bn | 1.0% | −36.2% | −102.4% | 2025 |
| 13 | Bio-rad Laboratories, Inc.BIO | $2.6bn | 0.7% | 29.4% | 10.8% | 2025 |
| 14 | Medpace Holdings, Inc.MEDP | $2.5bn | 20.0% | 17.8% | 70.2% | 2025 |
| 15 | Qiagen N.V.QGEN | $2.1bn | 5.7% | 20.3% | 11.6% | 2025 |
| 16 | Bio-TechneTECH | $1.2bn | −0.4% | 15.0% | 9.0% | 2026 |
| 17 | Sotera Health CoSHC | $1.2bn | 5.7% | 6.7% | 15.4% | 2025 |
| 18 | Repligen CorpRGEN | $738m | 16.4% | 6.6% | 2.4% | 2025 |
| 19 | Neogenomics IncNEO | $727m | 10.1% | −14.9% | −12.4% | 2025 |
| 20 | 10x Genomics, Inc.TXG | $643m | 5.2% | −6.8% | −5.8% | 2025 |
| 21 | Azenta, Inc.AZTA | $594m | 3.6% | −9.4% | −3.2% | 2025 |
| 22 | Veracyte, Inc.VCYT | $517m | 16.0% | 12.8% | 5.3% | 2025 |
| 23 | Twist Bioscience CorpTWST | $377m | 20.3% | −20.6% | −16.4% | 2025 |
| 24 | Castle Biosciences IncCSTL | $344m | 3.7% | −7.0% | −5.2% | 2025 |
| 25 | Fulgent Genetics, Inc.FLGT | $323m | 13.8% | −18.8% | −5.4% | 2025 |
| 26 | Billiontoone, Inc.BLLN | $305m | 100.0% | 2.4% | 6.5% | 2025 |
| 27 | Schrodinger, Inc.SDGR | $256m | 23.3% | −40.4% | −26.3% | 2025 |
| 28 | Mesa Laboratories IncMLAB | $249m | 3.4% | 2.7% | 3.9% | 2026 |
| 29 | Cytek Biosciences, Inc.CTKB | $201m | 0.5% | −33.0% | −18.0% | 2025 |
| 30 | Maravai Lifesciences Holdings, Inc.MRVI | $186m | −28.3% | −70.4% | −48.6% | 2025 |
| 31 | Cryoport, Inc.CYRX | $176m | 12.4% | 44.4% | 17.3% | 2025 |
| 32 | Pacific Biosciences Of California, Inc.PACB | $160m | 3.9% | −341.5% | — | 2025 |
| 33 | Grail, Inc.GRAL | $147m | 17.2% | −277.5% | −16.1% | 2025 |
| 34 | Quanterix CorpQTRX | $139m | 1.1% | −77.1% | −34.2% | 2025 |
| 35 | Mdxhealth SAMDXH | $108m | 19.8% | −31.1% | — | 2025 |
| 36 | Biodesix IncBDSX | $88m | 24.1% | −39.8% | — | 2025 |
| 37 | Harvard Bioscience IncHBIO | $87m | −8.1% | −65.5% | −147.1% | 2025 |
| 38 | Standard Biotools Inc.LAB | $85m | −6.2% | −87.8% | −16.7% | 2025 |
| 39 | Burning Rock Biotech LtdBNR | $75m | 4.7% | −10.3% | −9.9% | 2025 |
| 40 | Codexis, Inc.CDXS | $70m | 18.6% | −62.5% | −74.9% | 2025 |
| 41 | Personalis, Inc.PSNL | $70m | −17.7% | −116.7% | −35.0% | 2025 |
| 42 | Exagen Inc.XGN | $67m | 19.7% | −30.0% | −147.8% | 2025 |
| 43 | Champions Oncology, Inc.CSBR | $59m | 4.4% | −2.0% | −30.5% | 2026 |
| 44 | 908 Devices Inc.MASS | $56m | 17.7% | 34.7% | 15.1% | 2025 |
| 45 | Precipio, Inc.PRPO | $53m | 28.0% | −0.7% | −2.7% | 2025 |
| 46 | Alpha Teknova, Inc.TKNO | $41m | 7.4% | −42.6% | −22.8% | 2025 |
| 47 | Rapid Micro Biosystems, Inc.RPID | $34m | 19.7% | −140.3% | −86.8% | 2025 |
| 48 | Maxcyte, Inc.MXCT | $33m | −14.5% | −135.1% | −23.6% | 2025 |
| 49 | Bionano Genomics, Inc.BNGO | $29m | −7.4% | −92.6% | −66.2% | 2025 |
| 50 | Omniab, Inc.OABI | $19m | −29.3% | −347.0% | −23.4% | 2025 |
| 51 | Seer, Inc.SEER | $17m | 17.0% | −444.0% | −25.1% | 2025 |
| 52 | Bionexus Gene Lab CorpBGLC | $7m | −21.9% | −40.2% | −35.2% | 2025 |
| 53 | Quantum-si IncQSI | $2m | −20.3% | −4160.1% | −46.5% | 2025 |
| 54 | 20/20 Biolabs, Inc.AIDX | $2m | 16.7% | −182.8% | — | 2025 |
| 55 | Ispecimen Inc.ISPC | $2m | −79.2% | −543.7% | — | 2025 |
| 56 | Astrotech CorpASTC | $913,000 | −8.7% | −1580.2% | −75.4% | 2026 |
| 57 | YD Bio LtdYDES | $596,817 | 16.9% | −1392.6% | — | 2025 |
| 58 | Advanced Biomed Inc.ADVB | $127,637 | — | 5231.3% | 54.4% | 2026 |
| 59 | Sera Prognostics, Inc.SERA | $81,000 | 5.2% | −39417.3% | −51.8% | 2025 |
| 60 | Aclarion, Inc.ACON | $75,730 | 65.6% | −9551.9% | −104.8% | 2025 |
Other health care industries
- Managed Health Care8 companies
- Health Care Distributors9 companies
- Health Care Services48 companies
- Pharmaceuticals86 companies
- Health Care Equipment153 companies
- Biotechnology268 companies
- Health Care Facilities13 companies
- Hospitals5 companies
- Health Care Supplies13 companies
- Health Care Technology26 companies